VERA Vera Therapeutics Inc Total Asset Value of Company
Vera Therapeutics, Inc. (VERA) is a biopharmaceutical company developing targeted proteins for the therapy of kidney pathologies while strictly adhering to laboratory waste disposal regulations. The asset's market value dynamics show that total resources currently amount to 555.71. The startup's growth relies on attracting leading immunologists, who are offered stock option programs and creative independence to develop breakthrough medicines.
Analytical breakdowns and data insights for company Vera Pharma (VERA)
- market value and analyst target forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Vera Therapeutics, Inc.|VERA - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Vera Corp|VERA - Company Aggregate Debts|Debts to Book Capitalization Vera Corp|VERA - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Vera Therapeutics|Interim Coverage Ratio veratx.com
- net income and valuation multiples indicators:
Fundamental valuation:Vera Therapeutics, Inc.
AI-driven automation of drug synthesis requires significant capital expenditure in infrastructure, making resource monitoring critically important. By analyzing property and resource forecasts, an investor can see the total asset value reverse-calculated via ROA, which allows for an assessment of capital management efficiency and determines the real business resilience of Vera Therapeutics, Inc. (VERA) during costly clinical trials.
Key competitors
argenx.com (ARGX) - Company Total Assets|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets dianthustx.com|Cumulative Company Assets PHVS (Pharvaris)|ABCL (AbCellera Biologics) - Aggregate Asset Value|Company Total Assets TRML (Tourmaline Corp)|Company Total Asset Base Precigen Corp (PGEN)|PHAR - Aggregate Company Assets|nektar.com (NKTR) - Cumulative Company Assets|Upstream Bio (UPB) - Aggregate Company Assets|Cumulative Company Assets Zenas Bio|Cumulative Company Assets IMNM|Company Total Assets Gossamer Bio Corp.|Aggregate Company Assets KalVista Pharmaceuticals (KALV)|septerna.com - Total Business Assets|Company Total Assets PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Company Assets|RIGL: Cumulative Company Assets|ANAB: Aggregate Company Assets|ATXS: Company Total Assets|Company Assets engene.com (ENGN)|Aggregate Company Assets RAPT Therapeutics|JBIO: Aggregate Asset Value|Company Total Assets ACRS|Company Total Assets Kyverna Therapeutics, Inc (KYTX)|Tiziana Life Sciences - Cumulative Company Assets|Aggregate Asset Value CABA|VTYX: Cumulative Company Assets|Theratechnologies, Inc. - Aggregate Business Assets|AVTX: Company Total Assets|Eledon Pharmaceuticals, Inc - Aggregate Asset Value|AGEN (Agenus) - Company Total Assets|Company Assets climbbio.com CLYM|Aggregate Company Assets Zura Bio (ZURA)|ATYR (aTyr Pharma Inc) - Aggregate Asset Value|Company Total Assets ADAG (Adagene Inc.)|Company Total Assets ImageneBio IMA|STTK - Aggregate Company Assets|Total Asset Value of Company EQ|CNTB: Company Total Assets|Company Assets Immunic (IMUX)|Cumulative Company Assets ATRA|Company Total Assets InflaRx GmbH|Cumulative Company Assets XFOR (X4 Pharmaceuticals)|Aggregate Business Assets ACET|Company Total Assets CELU (Celularity)|Company Total Asset Base INmune Bio Inc (INMB)|Barinthus Bio - Company Total Assets|Kezar Life Sciences Inc (KZR) - Cumulative Company Assets|SAB Biotherapeutics (SABS) - Aggregate Company Assets|AKTX - Company Total Asset Base|Cumulative Company Assets ENLV|QTTB: Aggregate Asset Value|Company Total Assets GOVX|Company Total Asset Base Edesa Biotech Corp|Aggregate Company Assets iBio, Inc. IBIO|CARM: Total Business Assets|XTL Biopharmaceuticals Ltd. - Company Total Assets|Bolt Biotherapeutics (BOLT) - Cumulative Company Assets|HCWB (hcwbiologics.com) - Cumulative Company Assets|APVO - Company Total Asset Base|Cumulative Company Assets AIM|Aggregate Company Assets ADTX|Company Total Assets GRI|XRTX - Company Assets|Aggregate Company Assets ReShape Lifesciences HIND|Aggregate Asset Value REVB|Indaptus Therapeutics - Company Total Assets|SCNI - Company Total Assets|calcimedica.com (CALI) - Aggregate Company Assets|Total Asset Value of Company AFMD (Affimed N.V.)|ALLK (Allakos Inc) - Company Total Assets|HOOK: Aggregate Asset Value|Company Total Assets IGMS|Company Total Assets iteostherapeutics.com (ITOS)|Aggregate Company Assets Ocean Biomedical OCEA|Aggregate Asset Value TCBP|THRD - Aggregate Company Assets